/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES/
CARLETON PLACE, ON, Aug. 28, 2017 /CNW/ - RockGarden ("Company") is pleased to announce that it received its ACMPR ("Access to Cannabis for Medical Purposes Regulations") license from Health Canada on August 25th, 2017. With the granting of its license, RockGarden is permitted to begin cultivating medicinal cannabis at its facility, located in Carleton Place, Ontario. At the time of licensing, RockGarden became the 55th company in Canada to receive a cultivation license from Health Canada under the ACMPR program.
This latest milestone follows shortly after an announcement by the Company that it is raising $8.2 million from new and existing shareholders to expand production capacity to 2,080 kilograms of dried flower annually.
Deborah Hanscom, RockGarden's founder and CEO commented that, "today is an incredible day for RockGarden, and the community of Carleton Place, Ontario. When my son Andrew and I founded RockGarden in 2014, we dreamed of this day arriving. This incredible accomplishment could not have happened without the dedication, vision and fortitude of a group of talented individuals. We take seriously the responsibility and privilege that RockGarden assumes as a Licensed Producer of medical grade cannabis."
"RockGarden is thrilled to take our place in an industry that is being recognized internationally as the gold standard for government regulated cannabis programs," said Andrew Rock, Chief Operating Officer at RockGarden. "We have exciting plans to position RockGarden at the vanguard of our industry, and we extend our sincere gratitude to our colleagues at Health Canada for their incredible support and assistance during the application process."
RockGarden is a medical grade marijuana producer located in Carleton Place, Ontario. It recently announced a financing round to expand the footprint of its production facility, details of which can be found at http://www.rgcannabis.ca/. To read the press release related to the financing announcement, click here.
For further information: Deborah Hanscom, [email protected]